Moderna Co-Founder and Flagship Pioneering CEO on the Future of Biotech | WSJ News

The biotech industry saw reduced IPOs and investment in 2023. Is there reason for optimism? Noubar Afeyan, founder and chief executive officer of Flagship Pioneering, discusses innovations and trends in biotech that drive his 'paranoid optimism' in the industry.
#Biotechnology #Moderna #WSJ

[@solidorsharp3091]

IP = innovation stagnation $ ongoing monopolies preventing real competition $ real solutions that disrupt the status quo.

[@peterb3842]

Great question at @18:03.

[@longerino]

First impression of Noubar?? I think he is a salesman first.

[@labmaier3426]

New hype after Ai.

[@longerino]

What do you mean by "after"?